Electrical Impedance Tomography Imaging of Oxygen Therapy with High Flow Nasal Cannula in Patients with COVID-19 Acute Respiratory Distress Syndrome

DOI: https://doi.org/10.21203/rs.3.rs-1715795/v1

Abstract

Purpose

The aim of this study is to visualize the effect of a high flow nasal cannula  (HFNC) in patients with the diagnosis of COVID-19 acute respiratory distress syndrome (C-ARDS) followed up in intensive care unit (ICU) with the use of electrical impedance tomography (EIT).

Methods

Two different flow rates oxygen therapy in supine and prone positions were applied to the patients with HFNC. Patients’ EIT-based parameters (global inhomogeneity index (GI index), Center of Ventilation (CoV), Regional Ventilation Delay index (RVD index), Region of Interest Ratio (ROI ratio)), respiratory  and hemodynamic parameters were recorded from the database.

Results

Twenty patients were included in this retrospective observational study.When the flow rate gradually increased from baseline to 50 L/min and prone position; a significant and consistent descreasing trend of GI index: 0,55±0,02 (p < 0.0001), CoV: 42,98±0,93 (p <0.0001), RVD index: 3,38±1,13 (p = 0.006), ROI ratio:1,39±0,16 (p <0.0001), respiartory rate: 21,3±3,57 (p < 0.0001), mean arterial pressure: 81,5±10,95 (p=0.004) and inreasing PaO2/FiO2. ratio (partial arterial oxygen pressure/fraction of inspired oxygen): 203,1±33,44 ((p < 0.0001) were observed.

Conclusion

It was found that lung homogeneity in following C-ARDS patients in the prone position increases according to the evaluation of EIT parameters, respiratory and hemodynamic parameters.

Introduction

Respiratory failure is one of the main reasons for admission of COVID-19 patients to the intensive care unit (ICU) (1). Acute Respiratory Distress Syndrome (C-ARDS), which develops due to COVID-19, is a specific disease, although it can meet the Berlin criteria (2). Its main feature is the inconsistency of the severity of hypoxemia with the respiratory mechanics and the heterogeneity of the ventilation feature (3).

Gattinoni et al. (4) defined two types of the clinical picture in C-ARDS cases. In type 1, in addition to near-normal pulmonary compliance, the lung (AC?) fields that can be recruited are low, related to hypoxemia, hypoxic pulmonary vasoconstriction, and impaired pulmonary perfusion (5). Therefore, high PEEP on a mechanical ventilator and prone position does not improve oxygenation in Type 1 C-ARDS patients (6). On the other hand, in type 2 C-ARDS, there is decreased pulmonary compliance and less recruitable AC areas (7). In the clinical picture of these patients, there is severe hypoxemia and consequently increased inspiratory effort and high respiratory rate (6). Type 2 C-ARDS responds to a high PEEP, recruitment manoeuvre and prone position in the mechanical ventilator (6).

Oxygen therapy with a high-flow nasal cannula (HFNC) is a non-invasive and good option when hypoxia develops, but intubation indications do not occur in C-ARDS patients (8). HFNC therapy during the COVID-19 pandemic has attracted significant interest as a function as a bridge therapy before and after intubation in the ICU (9). Another method to improve gas exchange in ARDS patients is to follow the patient in the prone position (PP) (10). However, the response to PP in C-ARDS patients cannot be predicted and may differ in each patient (11).

The different phenotypes of C-ARDS require developing patient-specific personalised ventilation strategies (6). This is only possible with the simultaneous monitoring of the effects of invasive or non-invasive mechanical ventilation therapy applied to the patient with devices such as bedside electrical impedance tomography (EIT) (8). Although computed tomography (CT) is a valuable tool for imaging patients with C-ARDS, its routine use in COVID-19 patients is limited due to radiation load, cost, difficulties in dispatching the patient which whose general condition is critical, vital signs are unstable in ICU, to the CT room, and risk of contamination for healthcare workers (9).

Our study it is aimed to visualise the effect and efficacy of oxygen therapy at two different flow rates with HFNC in patients followed up with the diagnosis of C-ARDS with the use of EIT.

Material And Methods

Patient selection:

This study was planned after approval from the University Ethics Committee as a retrospective review of the hospital data of 20 patients who were diagnosed with COVID-19 confirmed by polymerase chain reaction (PCR) test, followed in the COVID ICU, and diagnosed with ARDS according to the Berlin Criteria (2). Posterior-anterior chest X-rays and thorax computed tomography images of the patients were consistent with the typical infiltration and ground glass images of COVID-19 ARDS.

Exclusion criteria from the study were accepted as being younger than 18 years of age, being pregnant and lactating, having a body mass index (BMI) above 50 kg/m2, having a rib cage malformation, presence of pneumothorax, and conditions where EIT monitoring is contraindicated (patients with automatic implantable cardioversion defibrillator, automatic drug pumps, patients with chest skin injury) (12).

The patients, which followed for COVID-19 ARDS and administered respiratory support with HFNC, demographic data, body mass indexes (BMI), APACHE-II score (Acute physiology and chronic health evaluation), ratios of PaO2 (partial oxygen pressure) in blood gas at baseline and during treatment, to FiO2 (percentage of oxygen delivered in HFNC) (PaO2/FiO2 ratios), respiratory rate (RR), peripheral oxygen saturation (SpO2), ROX index (SpO2/FiO2 ratio to RR) and hemodynamic parameters, including heart rate (HR) and mean arterial pressure (MAP), position information during therapy (supine-prone), flow values ​​applied in HFNC, and EIT images were obtained retrospectively from the recordings. All of the blood gases taken from the patients were taken at least 20 minutes after the treatment in order to reflect the position and flow changes in the blood gas parameters. In addition, if intubation was performed, the days of intubation, the days of discharge from ICU, and mortality rates were retrospectively scanned from the data registration form.

Study protocol:

In the study protocol, the flow rate of the HFNC was increased to two preset levels (30 L/min and 50 L/min), and each flow level was maintained for 20 minutes to a minimum. Patients were first held at 30 and 50 L/min in the supine position and then 30 and 50 L/min in the prone position in HFNC. Oxygen levels (FiO2) in the HFNC were adjusted so that the saturation levels of the patients would not decrease from 90–92% (for patients with Type 2 respiratory failure, the saturation would not fall below 88–90%).

As invasive mechanical ventilation indications: include level of consciousness (Glasgow coma score < 12), cardiac arrest/arrhythmias, severe hemodynamic instability (norepinephrine > 0.1 µg/kg/min and persistent or worsening respiratory status and lack of oxygenation (despite HFNC flow ≥ 50 L/min and FiO2 > 100) PaO2 < 60 mmHg), respiratory acidosis (PaCO2 > 50 mmHg, pH < 7.25), respiratory rate > 30 bpm or inability to clear secretions, and a ROX index below 2.85 were accepted (8).

For all patients followed up, the temperature was set to 37°C with the HFNC (Optiflow, Fisher & Paykel Healthcare, Auckland, Yeni Zelanda) humidifier (MR850, Fisher & Paykel Healthcare, Auckland, Yeni Zelanda), and oxygen was administered nasally with a medium silicone nasal cannula (RT050/051, Fisher & Paykel Healthcare, Auckland, New Zealand). The patients were asked to breathe through the nose, and their mouths and noses were covered with a simple surgical mask due to the risk of contamination. The different flow rates and position information in the study were recorded as follows:

T1: Baseline measurements are taken in the supine position before any therapy is started.

T2: HFNC in supine position with a flow rate of 30L/min

T3: HFNC in supine position with a flow rate of 50L/min

T4: HFNC in prone position with a flow rate of 30L/min

T5: HFNC in prone position with a flow rate of 50L/min

EIT measurements:

EIT measurements were performed on the Pulmovista 500 device (Dräger Medical, Lübeck, Germany), which is part of routine care in our clinic. For application, the silicone EIT belt with 16 surface electrodes was placed around the patients' rib cage in the fourth intercostal space and then connected to the EIT monitor for visualisation. Different reflections from AC and surrounding tissues were measured by applying alternating electrical currents to the body surface by utilising the potential change between neighbouring electrode pairs. The stimulation frequency and amplitude were adjusted automatically by the EIT device. EIT measurements were performed continuously at 20 Hz (13). When the patients were turned to the prone position, attention was paid to tying the EIT belt in the same spots by placing marker points so that the position of the EIT belt would not change. In addition, the data is digitally filtered with a cut-off frequency of 0.67 Hz to avoid reflection of heart-related impedance changes (13). EIT scans consist of 32x32 colour-coded matrix impedance images (13).

EIT data:

In the data obtained with EIT, AC regions are divided into four regions of interest (ROI): by recording regional changes of waveforms resulting from ventilation, non-dependant ROI1 and ROI2 show right and left ventral AC regions; ROI3 and ROI 4 show dependent right and left dorsal AC areas (9). The total ventilation of the four ROI areas is 100% and approximately 25% in each ROI region (14). The ROI ratio (also called ROI ratio or impedance ratio) is calculated as the ratio of the sum of the mean values ​​of the ventral AC areas (ROI 1 and 2) and the mean values ​​of the dependent dorsal AC areas (ROI 3 and 4) (15). An ROI ratio close to 1 was accepted as indicating a homogeneous distribution of ventilation (16). The present study examined the proportional changes of ROI areas in different flows and positions, and the homogeneity of ventilation was determined. Image reconstruction was performed using the algorithm in the software EIT Data Review Tool (Dräger Medical, Lübeck, Germany). EIT data were analysed offline using MATLAB R2015 (The MathWorks, Inc., Natic, MA) as programmed software.

EIT data analysis:

To reduce the heterogeneity of spontaneous breathing when analysing EIT data, an analysis of 5-minute continuous EIT data (data averaged) was performed at each flow rate (12, 17). Three parameters were examined to analyse the EIT data of patients treated with HFNC in spontaneous respiration using the software program. In addition to the software program used, it is possible to obtain the relevant parameters with the help of the formulas given below.

The Global Inhomogeneity index (GI index) was defined to measure the distribution of tidal volume in the lungs. It aimed to reduce the pulmonary impedance distribution pattern to a single number (13). The ideal value for healthy individuals is 0.5 (12). Increased GI index is in parallel with AC injury (18). It has been used to set the optimum positive end-expiratory pressure (PEEP) value in studies. The lowest possible GI index corresponds to the optimum PEEP level (13).

DI = differential impedance, DIxy = a defined pixel lung region, and DIlung = all pixels represented in AC (18).

The regional ventilation delay index (RVD index) was developed to further analyse regional ventilation (19). It expresses the time and delays from the beginning of inspiration to the opening of the closed alveoli (19). Although the RVD index was initially developed for slow flow manoeuvres during invasive mechanical ventilation, it was later used for spontaneous breathing studies. To avoid confusion, the RVD in spontaneous breathing studies was named RVDsponbreath (20). The value presented in our study is the RVDsponbreath value.

$${RVD}_{İ }=\frac{{t}_{i,40\%}}{{T}_{inspiration,global}} \times 100\%$$

ti40% indicates the time required to reach 40% of the maximum inspiratory impedance change, and Tinspiration,global indicates the expiration time calculated from the global impedance curve (19).

Center of ventilation (CoV) is a measure that defines the spatial distribution of ventilation (21). It was defined as the weighted average of the geometric centres of AC ventilation in the dorsal-ventral and right-left directions (21). A CoV value of 50% indicates that the ventilation distribution is centred in the dorsal-ventral direction of the thorax (13). A decrease in CoV values indicates that ventilation shifts towards non-dependent ventral AC regions due to the collapse of alveoli in dependent dorsal AC regions (13).

$$CoV=\frac{\sum ({y}_{i } \times {TV}_{i})}{{\sum TV}_{i}}\times 100$$

TVi represents the impedance change in EIT images, and the other value, Yi, is the pixel height scaled dorsal and ventrally (21).

STATISTICAL ANALYSIS:

Parametric tests were used without the normality test due to the compatibility of the Central Limit Theorem (22). In the data analysis, the mean and standard deviation were used when making the statistics of the continuous data, and the frequency and percentage values were used when defining the categorical variables. Repeated ANOVA test statistic was used to compare the means of more than two dependent groups. In case of difference between the means in more than two repeated measurements, pairwise comparisons were evaluated with the Bonferroni statistic. The statistical significance level of the data was taken as p < 0.05. In evaluating the data, www.e-picos.com, NY, New York Biostatistics software and MedCalc statistical package program were used.

Results

The mean age of 20 patients who met the study's inclusion criteria was 64.3 ± 10.6 years. Thirteen of the patients were male, and seven were female. The mean APACHE II score calculated in the first 24 hours of admission to the ICU was 16.3 ± 5.7, and the mean ROX indices calculated before starting the treatment were 5.5 ± 0.9. The detailed descriptive characteristics of the patients are summarised in Table-1 (pages 10–11).

Effects of HFNC therapy on different flow rates and prone position:

When the flow rate gradually increased from baseline to 50 L/min and prone position; a significant and consistent descreasing trend of GI index: 0,55 ± 0,02 (p < 0.0001), CoV: 42,98 ± 0,93 (p < 0.0001), RVD index: 3,38 ± 1,13 (p = 0.006), ROI ratio:1,39 ± 0,16 (p < 0.0001), respiartory rate: 21,3 ± 3,57 (p < 0.0001), mean arterial pressure: 81,5 ± 10,95 (p = 0.004) and inreasing PaO2/FiO2. ratio (partial arterial oxygen pressure/fraction of inspired oxygen): 203,1 ± 33,44 ((p < 0.0001), PCO2 (partial arterial carbon dioxide pressure): 39.65 ± 4.28 (p = 0.01) were observed in Table 2 (page 11).

As a result of pairwise comparison of repeated measurements of EIT Parameters, Respiratory and Hemodynamic Parameters:

Table 3 shows a significant difference between repeated measurements of the measurement parameter in terms of GI index (p < 0.05). Among the five measurements made for the GI index, It was observed that the difference between the mean measurements taken at T1-T2, T1-T3, T1-T4, T1-T5, T2-T4, T2-T5, T3-T4, T3-T5 and T4-T5 time intervals was statistically significant (p < 0.05) (Table 3; pages 12, 13,14).

Table 3 shows a significant difference between repeated measurements of the measurement parameter in terms of CoV (p < 0.05). Among the five measurements made for CoV, the difference between the mean measurements taken at T1-T4, T2-T4, T3-T4 and T4-T5 time intervals was statistically significant (Table 3; pages 12, 13,14) (p < 0.05).

Table 3 shows a significant difference between repeated measurements of the RVD index measurement parameter (p < 0.05). Among the five measurements made for RDV, the difference between the mean measurements taken at T3-T5 time intervals was found to be statistically significant (Table 3; pages 12, 13,14) (p < 0.05).

Table 3 shows a significant difference between repeated measurements of the ROI ratio measurement parameter (p < 0.05). Among the five measurements made for ROI ratio, it was observed that the difference between the measurement averages taken at each time interval was statistically significant (Table 3; pages 12, 13,14)) (p < 0.05).

Table 3 shows a significant difference between repeated measurements of the P/F ratio measurement parameter (p < 0.05). Among the five measurements made for the P/F ratio, it was seen that the difference between the measurement averages taken at all time intervals was statistically significant (Table 3; pages 12, 13,14) (p < 0.05).

Table 3 shows a significant difference between repeated measurements of the CO2 parameter (p < 0.05). Among the five measurements made for CO2, the difference between the mean measurements taken at T2-T3, T2-T5 and T4-T5 time intervals was found to be statistically significant (Table 3; pages 12, 13,14) (Table 3, page 11) (p < 0.05).

Table 3 shows a significant difference between repeated measurements of the RR measurement parameter (p < 0.05). It was observed that the difference between the means of measurements taken at all time intervals from the five measurements made for RR was statistically significant (Table 3; pages 12, 13,14) (p < 0.05).

Table 3 shows a significant difference between repeated measurements of the MAP measurement parameter (p < 0.05). Among the five measurements for MAP, the difference between the mean measurements taken at T1-T4 time intervals was found to be statistically significant (Table 3; pages 12, 13,14) (p < 0.05).

The change in evolution of estimated marginal means of GI index, CoV, RVD index, P/F ratio, PCO2, respiratory rate, mean arterial pressure and ROI ratio are provided in Figs. 18. EIT images is reconstruction by MATLAB in Figs. 9.

Discussion

Our study investigated the EIT parameters and respiratory and hemodynamic parameters of C-ARDS patients treated with HFNC. When the flow rate gradually increased from baseline to 30L/min-50 L/min and prone position; a significant and consistent descreasing trend of GI index, CoV, RVD index, ROI ratio, respiartory rate, mean arterial pressure and inreasing P/F ratio.

In the study, based on the GI index and CoV, which are the EIT parameters, we found that when we followed the patients in the prone position and at a flow rate of 30 L/min in HFNC, the heterogeneity in the ARDS lung decreased and the homogeneity increased. Similarly, when evaluated according to the ROI ratio, the lung heterogeneity decreased in the prone position and at low flow rate. In the RVD index, we found that the difference between the supine flow rate of 50 L/min and the flow rate of 50 L/min in the prone position was statistically significant.

High dynamic lung tension (caused by tidal volume) and static lung tension (caused by PEEP administration) during invasive mechanical ventilation therapy are associated with lung injury (23). However, little is known about the effect of flow rates followed in spontaneous breathing and applied in HFNC treatment on AC fields (9). HFNC reduces inspiratory effort, improves lung mechanics, and reduces minute volume by affecting PEEP (24). However, the main challenge here is to find the individualised optimum flow rate in HFNC therapy, just as the optimal PEEP for each patient in invasive mechanical ventilation therapy. HFNC flow rates are heterogeneous, ranging from 15 L/min to 100 L/min (25). To evaluate the effects of different HFNC flow rates on AC, EIT-based and most commonly used GI index, CoV, RVD index, and ROI ratio parameters were used in this study (13).

The GI index is a functional EIT parameter widely used to measure the heterogeneity of lung ventilation (13). When the GI index values in our study were examined, we found that ventilation was homogeneously distributed at 30 L/min and 50 L/min flow rates in the prone position compared to baseline values before treatment. We found that the GI index at a flow rate of 30 L/min in the prone position was 0.5 ± 0.01 and almost homogeneous. This result shows that it may be beneficial to increase the flow rate in HFNC by titration in case of improvement in P/F ratios and a decrease in respiratory rate.

On the other hand, although it was determined that the GI index decreased and homogeneity increased at 30 L/min and 50 L/min flow rates in the supine position compared to the pre-treatment values, there was no statistically significant difference between this position and these flow rates. Similarly, in Li Z. et al.'s (8) study, no statistically significant difference was found in the GI index in the measurements they made at different flow rates after HFNC treatment was started in the supine position. It was found that the difference in our study was due to the fact that the patients were followed in the prone position, and therefore, the GI index level decreased, and homogeneity increased in the prone position compared to the supine position. As in ARDS patients, the rationale for following the patient in the prone position in C-ARDS patients is to ensure that the atelectatic areas in the dependent dorsal region are included in ventilation and to reduce heterogeneous ventilation (26).

At the same time, the prone position reduces the ventilation/perfusion mismatch, hypoxemia, and shunt, which is typical of ARDS (1). Because when the patient is in the prone position, the pleural pressure gradient between the dependent and non-dependent region decreases as a result of gravity; thus, a more homogeneous lung is formed (27).

Another EIT parameter that measures ventilation distribution is CoV. When the CoV values ​​in this study were examined, the CoV value at a flow rate of 30L/min in the prone position was 50.67 ± 1.33. This value indicates that the ventilation distribution is centred in the dorsal-ventral direction of the thorax (14). CoV values ​​were decreased at HFNC supine 30L/min, 50 L/min and prone 50L/min flow rates. This can be explained by the shift of ventilation from the dorsal AC areas to the ventral AC fields in ARDS patients, resulting in increased aeration and even overdistension in the ventral region while decreasing and causing atelectasis in the dorsal regions (28).

Similarly, Li Z. et al. (8), in their study, found that ventilation was reduced in the dorsal regions of the lung in patients in whom HFNC treatment was unsuccessful. This resulted in increased respiratory effort, shortened inspiratory time, decreased minute volume, and inadequate oxygenation in the patients' group. Similarly, in our study, respiratory rate and P/F ratios were found to be higher and P/F ratios lower in the supine position, where the CoV value was low and heterogeneous AC characteristics persisted, compared to the prone position. Lehmann S. et al. (29) found that ventilation was displaced due to gravity in patients with multiple trauma who were placed in the lateral position with EIT in their study.

In our study of the other EIT parameter, the RVDsponbreath index, a significant difference was found only between 50 L/min in the supine position and 50 L/min in the prone. This can be explained by the inspiratory time being too short during spontaneous breathing to calculate a fixed RVD index (30). Bickenbach et al. (16) found the RVDsponbreath index to be statistically significant in their study of spontaneous breathing trials in prolonged weaning (30). However, RVDsponbreath is strongly dependent on the individual variation, depth, and respiratory rate of the patient's spontaneous breathing (16). Therefore, when calculating the RVDsponbreath value, a sequence with spontaneous respirations should be selected (16). Although a 5-minute sequence was chosen to reduce the heterogeneity of spontaneous breathing, only the RVDsponbreath between the two times was statistically significant. As a result, RVD, which was initially developed to measure slow flow in mechanical ventilators, is used during spontaneous breathing, but it is incomprehensible among patients (20).

It is a cheap, simple and effective method to follow the patient in the prone position in ARDS patients and has a 15% benefit on absolute survival (31). It also significantly improves arterial oxygenation compared to the supine position (32). In the study we presented, significant improvements were found in P/F ratios, RR, and MAP in patients placed in the prone position. In previous studies, there are findings that a prone position can reduce ventilator-related lung damage and improve respiratory and hemodynamic parameters (33). On the other hand, in a large, randomised study conducted in recent years, the P/F ratio was found to be similar between survivors and non-survivors in ARDS patients (34). The effectiveness of the prone position at the individual patient level may depend on the sub-phenotypes of ARDS, as in C-ARDS (35).

Another parameter developed to monitor the physiological effects of EIT, which is the dynamic monitoring of regional lung mechanics at the bedside, is the ROI ratio (13). The value obtained by the ratio of the dependent ROI areas to the non-depending ROI areas approached the value of 1 at a flow rate of 30 L/min in the prone position in our study. This shows the homogeneity of AC ventilation. In the COVID-19 ARDS case report presented by Tomasino S. et al. (15), while the patient with Gattinoni type I ARDS had an ROI ratio of 1 in the supine position, the value decreased in the prone position, overdistension occurred, and oxygenation did not improve. More studies are needed to predict the ROI ratio, ARDS subtype, and future treatment.

Limitations:

In our study, in which the effects of HFNC application with EIT have monitored in patients followed up with the diagnosis of C-ARDS, the sample size was limited. However, the sample size could not be calculated since there has been no previous study on this subject in the literature. Since our study is a pioneering study in its field, it is necessary to carry out studies with larger sample groups in the future.

Conclusion

The COVID-19 pandemic still remains a cause for global concern. EIT is a non-invasive, radiation-free clinical imaging tool. EIT has the potential to monitor the effectiveness of the prone position and to determine flow rates in HFNC treatment in COVID-19 ARDS patients. Positioning the patient, which can simply be summarised as "keep the healthy lung down", is an effective treatment option to improve ventilation. According to the authors' literature knowledge, our study is promising because it is the first study in the world to examine HFNC treatment in COVID-19 patients with EIT and the first EIT study in our country.

Declarations

Funds

No institutional departmental funds were received in the conduct of the study.

Conflict of interest

Authors have not disclosed any potential conflicts of interest.

References

  1. Perier F, Tuffet S, Maraffi T, Alcala G, Victor M, Haudebourg AF, et al. Electrical impedance tomography to titrate positive end-expiratory pressure in COVID-19 acute respiratory distress syndrome. Crit Care. 2020;24(1):678.
  2. Ferguson ND, Fan E, Camporota L, Antonelli M, Anzueto A, Beale R, et al. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med. 2012;38(10):1573-82.
  3. Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020;201(10):1299 − 300.
  4. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099 − 102.
  5. Marini JJ, Gattinoni L. Management of COVID-19 Respiratory Distress. Jama. 2020;323(22):2329-30.
  6. Goligher EC, Ranieri VM, Slutsky AS. Is severe COVID-19 pneumonia a typical or atypical form of ARDS? And does it matter? Intensive Care Med. 2021;47(1):83 − 5.
  7. Chiumello D, Busana M, Coppola S, Romitti F, Formenti P, Bonifazi M, et al. Physiological and quantitative CT-scan characterization of COVID-19 and typical ARDS: a matched cohort study. Intensive Care Med. 2020;46(12):2187-96.
  8. Li Z, Zhang Z, Xia Q, Xu D, Qin S, Dai M, et al. First Attempt at Using Electrical Impedance Tomography to Predict High Flow Nasal Cannula Therapy Outcomes at an Early Phase. Front Med (Lausanne). 2021;8:737810.
  9. Zhang R, He H, Yun L, Zhou X, Wang X, Chi Y, et al. Effect of postextubation high-flow nasal cannula therapy on lung recruitment and overdistension in high-risk patient. Crit Care. 2020;24(1):82.
  10. Gattinoni L, Busana M, Giosa L, Macrì MM, Quintel M. Prone Positioning in Acute Respiratory Distress Syndrome. Semin Respir Crit Care Med. 2019;40(1):94–100.
  11. Coppo A, Bellani G, Winterton D, Di Pierro M, Soria A, Faverio P, et al. Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study. Lancet Respir Med. 2020;8(8):765 − 74.
  12. Mauri T, Alban L, Turrini C, Cambiaghi B, Carlesso E, Taccone P, et al. Optimum support by high-flow nasal cannula in acute hypoxemic respiratory failure: effects of increasing flow rates. Intensive Care Med. 2017;43(10):1453-63.
  13. Putensen C, Hentze B, Muenster S, Muders T. Electrical Impedance Tomography for Cardio-Pulmonary Monitoring. J Clin Med. 2019;8(8).
  14. Kunst PW, de Vries PM, Postmus PE, Bakker J. Evaluation of electrical impedance tomography in the measurement of PEEP-induced changes in lung volume. Chest. 1999;115(4):1102-6.
  15. Tomasino S, Sassanelli R, Marescalco C, Meroi F, Vetrugno L, Bove T. Electrical Impedance Tomography and Prone Position During Ventilation in COVID-19 Pneumonia: Case Reports and a Brief Literature Review. Semin Cardiothorac Vasc Anesth. 2020;24(4):287 − 92.
  16. Bickenbach J, Czaplik M, Polier M, Marx G, Marx N, Dreher M. Electrical impedance tomography for predicting failure of spontaneous breathing trials in patients with prolonged weaning. Crit Care. 2017;21(1):177.
  17. Corley A, Caruana LR, Barnett AG, Tronstad O, Fraser JF. Oxygen delivery through high-flow nasal cannulae increase end-expiratory lung volume and reduce respiratory rate in post-cardiac surgical patients. Br J Anaesth. 2011;107(6):998–1004.
  18. Zhao Z, Möller K, Steinmann D, Frerichs I, Guttmann J. Evaluation of an electrical impedance tomography-based Global Inhomogeneity Index for pulmonary ventilation distribution. Intensive Care Med. 2009;35(11):1900-6.
  19. Muders T, Luepschen H, Zinserling J, Greschus S, Fimmers R, Guenther U, et al. Tidal recruitment assessed by electrical impedance tomography and computed tomography in a porcine model of lung injury*. Crit Care Med. 2012;40(3):903 − 11.
  20. Wrigge H, Zinserling J, Muders T, Varelmann D, Günther U, von der Groeben C, et al. Electrical impedance tomography compared with thoracic computed tomography during a slow inflation maneuver in experimental models of lung injury. Crit Care Med. 2008;36(3):903-9.
  21. Frerichs I, Hahn G, Golisch W, Kurpitz M, Burchardi H, Hellige G. Monitoring perioperative changes in distribution of pulmonary ventilation by functional electrical impedance tomography. Acta Anaesthesiol Scand. 1998;42(6):721-6.
  22. Norman G. Likert scales, levels of measurement and the "laws" of statistics. Adv Health Sci Educ Theory Pract. 2010;15(5):625 − 32.
  23. Terragni PP, Rosboch G, Tealdi A, Corno E, Menaldo E, Davini O, et al. Tidal hyperinflation during low tidal volume ventilation in acute respiratory distress syndrome. Am J Respir Crit Care Med. 2007;175(2):160-6.
  24. Bräunlich J, Beyer D, Mai D, Hammerschmidt S, Seyfarth HJ, Wirtz H. Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration. 2013;85(4):319 − 25.
  25. Hernández G, Vaquero C, González P, Subira C, Frutos-Vivar F, Rialp G, et al. Effect of Postextubation High-Flow Nasal Cannula vs Conventional Oxygen Therapy on Reintubation in Low-Risk Patients: A Randomized Clinical Trial. Jama. 2016;315(13):1354-61.
  26. Guérin C, Albert RK, Beitler J, Gattinoni L, Jaber S, Marini JJ, et al. Prone position in ARDS patients: why, when, how and for whom. Intensive Care Med. 2020;46(12):2385-96.
  27. Munshi L, Del Sorbo L, Adhikari NKJ, Hodgson CL, Wunsch H, Meade MO, et al. Prone Position for Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2017;14(Supplement_4):S280-s8.
  28. Bachmann MC, Morais C, Bugedo G, Bruhn A, Morales A, Borges JB, et al. Electrical impedance tomography in acute respiratory distress syndrome. Critical Care. 2018;22(1):1–11.
  29. Lehmann S, Leonhardt S, Ngo C, Bergmann L, Schrading S, Heimann K, et al. Electrical impedance tomography as possible guidance for individual positioning of patients with multiple lung injury. The clinical respiratory journal. 2018;12(1):68–75.
  30. Yang L, Dai M, Cao X, Möller K, Dargvainis M, Frerichs I, et al. Regional ventilation distribution in healthy lungs: can reference values be established for electrical impedance tomography parameters? Ann Transl Med. 2021;9(9):789.
  31. Dalla Corte F, Mauri T, Spinelli E, Lazzeri M, Turrini C, Albanese M, et al. Dynamic bedside assessment of the physiologic effects of prone position in acute respiratory distress syndrome patients by electrical impedance tomography. Minerva Anestesiol. 2020;86(10):1057-64.
  32. Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368(23):2159-68.
  33. Abroug F, Ouanes-Besbes L, Elatrous S, Brochard L. The effect of prone positioning in acute respiratory distress syndrome or acute lung injury: a meta-analysis. Areas of uncertainty and recommendations for research. Intensive Care Med. 2008;34(6):1002-11.
  34. Albert RK, Keniston A, Baboi L, Ayzac L, Guérin C. Prone position-induced improvement in gas exchange does not predict improved survival in the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2014;189(4):494-6.
  35. Famous KR, Delucchi K, Ware LB, Kangelaris KN, Liu KD, Thompson BT, et al. Acute Respiratory Distress Syndrome Subphenotypes Respond Differently to Randomized Fluid Management Strategy. Am J Respir Crit Care Med. 2017;195(3):331-8.

Tables

Table 1. Main characteristics of the study population

Patients

Age

F/M

APACHEII

BMI

ROX

INDEX

Days of intubation

Days of mortality

Days of discharge

MALIGNITY

Yes/NO

DM

YES/NO

HT

YES/NO

CRF

YES/NO

CAD

YES/NO

ARF

YES/NO

1

79

M

22

31

4,46

5

9


1

0

0

0

0

0

2

53

M

5

37

5,89

-

-

12

0

1

1

0

0

0

3

66

F

24

31

6,01

-

-

14

0

1

1

0

0

0

4

59

M

15

27

5,72

-

-

4

0

0

1

0

0

0

5

60

F

8

28

6,67

-

-

4

0

0

1

0

0

0

6

70

M

12

26

5,69

-

-

1

0

1

1

0

0

0

7

72

M

14

28

5,96

-

-

6

0

0

1

1

0

0

8

68

M

19

32

6,72

-

-

10

0

0

1

0

0

0

9

75

F

26

27

4,25

6

10

-

0

1

1

0

1

0

10

66

M

16

30

6,56

-

-

9

0

0

1

0

0

1

11

54

M

16

26

7,38

-

-

6

0

1

0

0

0

0

12

39

F

14

34

4,47

-

-

8

0

0

1

0

0

0

13

65

F

21

24

4,37

2

12

-

0

0

0

1

1

0

14

68

M

11

21

6,23

-

-

5

0

0

1

0

0

0

15

57

M

9

23

6,41

-

-

8

0

1

1

0

0

1

16

49

F

18

25

4,36

7

13

-

0

0

1

1

0

1

17

61

M

14

26

4,48

-

-

11

0

1

1

0

0

0

18

76

M

16

31

4,78

3

9

-

0

1

0

1

0

0

19

67

F

22

32

4,95

2

5

-

0

1

1

1

0

0

20

82

M

24

23

4,87

1

3

-

0

1

1

0

0

0

 Summary

 64,3±10,6

 7/13

 16,3±5,7

 28,1±4,1

5,5±0,9

3,7±2,2

8,7±3,6

7,5±3,6

1/19

10/10

16/4

5/15

2/18

3/17

Abbreviation: F: female, M:Male , APACHE II: Acute physiology and chronic health evaluation, BMI:Body Mass İndex, ROX index: SpO2/FiO2 ratio to respiratory rate, DM: Diabetes Mellitus, HT:Hipertansion, CRF:Chronic Renal Failure, CAD: Coronary Artery Disease, ARF: Acute Renal Failure

Table 2. Difference Statistics in Repeated Measurements of EIT Parameters, Respiratory and Hemodynamic Parameters (n=20)77

 

T1

T2

            T3

T4

T5

p value

Variables

x̄±SD

x̄±SD

x̄±SD

x̄±SD

x̄±SD

 

GI INDEX

0,68±0,03

0,59±0,02

0,61±0,02

0,5±0,01

0,55±0,02

<0,0001

COV

42,64±1,84

44,53±2,01

43,7±1,05

50,67±1,33

43,98±0,93

<0,0001

P/F ratio

104,8±15,23

123,3±22,95

130±23,61

147,85±28,35

203,1±33,44

<0,0001

PCO2

34,85±7,37

33,45±5,22

36,65±4,15

35,25±2,55

39,65±4,28

0,01

RR

40,95±3,69

33,25±3,69

31,05±3,43

26,3±3,19

21,3±3,57

<0,0001

MAP

90,3±7,88

87,85±12,65

81,35±14,74

78,25±10,35

81,5±10,95

0,004

RVD index

4,21±0,5

4,11±0,74

4,24±0,59

4,08±0,71

3,38±1,13

0,006

ROI ratio

2,005±0,14

1,83±0,22

1,68±0,23

1,11±0,08

1,39±0,16

<0,0001

 

Abbreviation: GI Index: Global Homogeneity Index,  Cov: Center Of Ventilation,  RVD: Regional Ventilation Delay Index,  ROI Ratio: ROI1+ROI2/ROI3+ROI4.

P/F Ratio: PaO2/FiORatio,   PCO2:CO2 level In Arterial Blood Gas, RR: Respiratory Rate,  MAP: Mean Arterial Pressure

Table 3. Pairwise Comparison Statistics for Repeated Measurements of EIT Parameters, Respiratory and Hemodynamic Parameters and Traits (n=20)


Mean Difference

p value

95% Confidence Interval for Difference

 TIME



Lower Bound

Upper Bound

GI INDEX

T1-T2

,09*

<0,0001

0,07

0,11

T1-T3

0,07*

<0,0001

0,04

0,09

T1-T4

0,18*

<0,0001

0,16

0,2

T1-T5

0,13*

<0,0001

0,09

0,15

T2-T3

-0,21

0,06

-0,04

0,001

T2-T4

0,09*

<0,0001

0,08

0,11

T2-T5

0,04*

<0,0001

0,02

0,06

T3-T4

0,12*

<0,0001

0,09

0,14

T3-T5

0,06*

<0,0001

0,04

0,09

T4-T5

-0,05*

<0,0001

-0,07

-0,04

CoV

 

 

 

 

T1-T2

-0,89

0,99

-2,78

0,99

T1-T3

-0,06

0,99

-1,78

1,66

T1-T4

-7,02*

<0,0001

-8,45

-5,6

T1-T5

-0,34

0,99

-1,69

1,01

T2-T3

0,83

0,99

-0,81

2,47

T2-T4

-6,13*

<0,0001

-7,98

-4,29

T2-T5

0,54

0,99

-0,91

1,99

T3-T4

-6,96*

<0,0001

-8,02

-5,91

T3-T5

-0,28

0,99

-1,42

0,85

T4-T5

6,68*

<0,0001

5,46

7,9

P/F ratio

 

 

 

 

T1-T2

-18,5*

0,01

-33,84

-3,16

T1-T3

-25,2*

<0,0001

-39,91

-10,49

T1-T4

-43,05*

<0,0001

-61,14

-24,96

T1-T5

-98,3*

<0,0001

-122,25

-74,35

T2-T3

-6,7*

0,03

-13,06

-0,34

T2-T4

-24,55*

<0,0001

-32,57

-16,53

T2-T5

-79,8*

<0,0001

-100,67

-58,93

T3-T4

-17,85*

<0,0001

-26,81

-8,89

T3-T5

-73,1*

<0,0001

-95,35

-50,84

T4-T5

-55,25*

<0,0001

-76,45

-34,05

pCO2

 

 

 

 

T1-T2

1,4

0,99

-5,64

8,44

T1-T3

-1,8

0,99

-7,3

3,71

T1-T4

-0,4

0,99

-4,97

4,17

T1-T5

-4,8

0,32

-11,37

1,77

T2-T3

-3,2*

0,02

-6,07

-0,39

T2-T4

-1,8

0,99

-6,03

2,43

T2-T5

-6,2*

0,004

-10,79

-1,61

T3-T4

1,4

0,99

-2,05

4,85

T3-T5

-3

0,65

-7,86

1,86

T4-T5

-4,4*

0,002

-7,46

-1,34

RR

 

 

 

 

T1-T2

7,7*

<0,0001

5,25

10,15

T1-T3

9,9*

<0,0001

6,74

13,06

T1-T4

14,65*

<0,0001

11,88

17,42

T1-T5

19,65*

<0,0001

16,16

23,14

T2-T3

2,2*

0,04

0,09

4,31

T2-T4

6,95*

<0,0001

5,09

8,81

T2-T5

11,95*

<0,0001

9,68

14,22

T3-T4

4,75*

<0,0001

3,58

5,92

T3-T5

9,75*

<0,0001

8,43

11,07

T4-T5

5*

<0,0001

3,72

6,28

MAP

 

 

 

 

T1-T2

2,45

0,99

-9,09

13,99

T1-T3

8,95

0,32

-3,3

21,2

T1-T4

12,05*

<0,0001

4,81

19,29

T1-T5

8,8

0,11

-1,08

18,67

T2-T3

6,5

0,12

-0,87

13,87

T2-T4

9,6

0,08

-0,66

19,86

T2-T5

6,35

0,87

-4,79

17,49

T3-T4

3,1

0,99

-5,81

12,01

T3-T5

-0,15

0,99

-10,8

10,5

T4-T5

-3,25

0,99

-12,98

6,49

RVD index

 

 

 

 

T1-T2

0,09

0,99

-0,57

0,75

T1-T3

-0,3

0,99

-0,61

0,54

T1-T4

0,13

0,99

-0,5

0,76

T1-T5

0,83

0,11

-0,09

1,76

T2-T3

-0,12

0,99

-0,84

0,59

T2-T4

0,04

0,99

-0,64

0,73

T2-T5

0,74

0,44

-0,35

1,82

T3-T4

0,16

0,99

-0,49

0,81

T3-T5

0,86*

0,052

0,006

1,73

T4-T5

0,69

0,43

-0,32

1,72

ROI ratio

 

 

 

 

T1-T2

0,18*

<0,0001

0,08

0,28

T1-T3

0,32*

<0,0001

0,22

0,43

T1-T4

0,9*

<0,0001

0,79

1,008

T1-T5

0,61*

<0,0001

0,52

0,7

T2-T3

0,15*

<0,0001

0,06

0,24

T2-T4

0,72*

<0,0001

0,57

0,88

T2-T5

0,44*

<0,0001

0,33

0,54

T3-T4

0,58*

<0,0001

0,42

0,73

T3-T5

0,29*

<0,0001

0,19

0,38

T4-T5

-0,29*

<0,0001

-0,38

-0,19

Abbreviation: GI Index: Global Homogeneity Index    Cov: Center of Ventilation, RVD: Regional Ventilation Delay Index, ROI Ratio: ROI1+ROI2/ROI3+ROI4.   

P/F Ratio: PaO2/FiORatio,  PCO2:CO2 level In Arterial Blood Gas, RR: Respiratory Rate,  MAP: Mean Arterial Pressure  

* The mean difference is significant at the 0,05 level. Adjustment for multiple comparisons: Bonferro